CCL

Összesen 2 találat.
#/oldal:
Részletezés:
Rendezés:

1.

001-es BibID:BIBFORM040285
Első szerző:Conlon, J. Michael
Cím:A melittin-related peptide from the skin of the Japanese frog, Rana tagoi, with antimicrobial and cytolytic properties / Conlon J. M., Sonnevend A., Patel M., Camasamudram V., Nowotny N., Zilahi E., Iwamuro S., Nielsen P. F., Pál T.
Dátum:2003
Megjegyzések:Two peptides with antimicrobial and cytolytic properties were purified from an extract of the skin of Tago's brown frog Rana tagoi. The primary structure of one peptide (FLPILGKLLS(10)GIL.NH(2)) identifies it as a member of the temporin family, whereas the second peptide (AIGSILGALA(10)KGLPTLISWI(20)KNR.NH(2)) displays 78% sequence identity to melittin from the venom of the honeybee Apis florea. Compared with melittin, the melittin-related peptide (MRP) was equipotent in inhibiting the growth of the Gram-positive bacterium Staphylococcus aureus, 5-fold less potent against the Gram-negative bacterium Escherichia coli and against the fungal pathogen, Candida albicans. MRP was 13-fold less hemolytic than melittin against human erythrocytes and 4- and 5-fold less cytolytic against mouse EL4 T-lymphoma-derived cells and L929 fibroblasts, respectively. However, at non-cytotoxic concentrations (<or=8 microM), MRP did not protect HeLa cells from cell death produced by human rhinovirus type 2 infection.
Tárgyszavak:Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Frog skin
Melittin
Temporin
Hemolytic
Cytolytic
Antimicrobial
Antiviral
Megjelenés:Biochemical and Biophysical Research Communications. - 306 : 2 (2003), p. 496-500. -
További szerzők:Sonnevend Ágnes Patel, Mahendra Camasamudram, Vijayayasarathy Nowotny, Norbert Zilahi Erika (1964-) (molekuláris biológus) Iwamuro, Shawichi Nielsen, Per F. Pál Tibor
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
DOI
Borító:

2.

001-es BibID:BIBFORM072401
Első szerző:Pál Ildikó (belgyógyász szakorvos)
Cím:The Impact of Drug Metabolism Gene Polymorphisms on Therapeutic Response and Survival in Diffuse Large B-Cell Lymphoma Patients / Ildikó Pál, Árpád Illés, Lajos Gergely, Tibor Pál, Zita Radnay, Zoltán Szekanecz, Erika Zilahi, László Váróczy
Dátum:2018
ISSN:1565-1088
Megjegyzések:Background: Diffuse large B-cell lymphoma (DLBCL) accountsfor 30% of all non-Hodgkin lymphomas (NHL) and 80% ofagressive lymphomas. Besides the traditional InternationalPrognostic Index (IPI), some other factors may also influencethe prognosis of DLBCL patients.Objectives: To study how the genetic polymorphisms in themetabolic pathway influence the event-free and overall survivalsand therapeutic responses in DLBCL.Methods: The study was comprised of 51 patients (32 men, 19women). The average age was 53.1 years. DLBCL was diagnosedbetween 2011 and 2016 and the average follow-up time was3.78 years. These patients received 1?8 cycles (an average of6.2 cycles) of rituximab, cyclophosphamide, doxorubicin, vincristin,prednisolon (R-CHOP) immunochemotherapy. Real-timepolymerase chain reaction was used to determine the geneticpolymorphisms of CYP2E1, GSTP1, NAT1, and NAT2 genes.Results: Our results showed that the polymorphisms of CYP2E1,GSTP1, and NAT1 genes did not influence the prognosis ofDLBCL patients significantly. In terms of the NAT2 gene, GGhomozygous patients showed slightly better therapeuticresponse and survival results compared to those bearing an Aallele; however, the differences were not statistically significant.Conclusions: Our results could not confirm that genetic polymorphismin metabolic pathways has any predictive role inDLBCL.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
genetic polymorphism
non-Hodgkin lymphoma (NHL)
event-free survival
therapeutic efficacy
diffuse large B-cell lymphoma (DLBCL)
Megjelenés:Israel Medical Association Journal. - 20 : 4 (2018), p. 217-221. -
További szerzők:Illés Árpád (1959-) (belgyógyász, haematológus, onkológus) Gergely Lajos (1965-) (belgyógyász, haematológus) Pál Tibor Radnay Zita (1985-) (belgyógyász) Szekanecz Zoltán (1964-) (reumatológus, belgyógyász, immunológus) Zilahi Erika (1964-) (molekuláris biológus) Váróczy László (1974-) (belgyógyász, haematológus)
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Rekordok letöltése1